Showing results (181-190 of 253) with videos related to

Sort By:
Pageof 26
Acta Biomaterialia|October 2, 2024
Elucidating the unexpected cell adhesive properties of agarose substrates. The effect of mechanics, fetal bovine serum and specific peptide sequencesFrancesco Piazza, Beatrice Ravaglia, Andrea Caporale, et al.
Frontiers in Cell and Developmental Biology|August 29, 2022
Protein Kinase CK2 represents a new target to boost Ibrutinib and Venetoclax induced cytotoxicity in mantle cell lymphomaSabrina Manni, Maria Pesavento, Zaira Spinello, et al.
Histopathology|June 20, 2017
Aberrant expression of CD10 and BCL6 in mantle cell lymphomaMarco Pizzi, Claudio Agostinelli, Simona Righi, et al.
Cancers|December 11, 2019
In Chronic Lymphocytic Leukemia the JAK2/STAT3 Pathway Is Constitutively Activated and Its Inhibition Leads to CLL Cell Death Unaffected by the Protective Bone Marrow MicroenvironmentFilippo Severin, Federica Frezzato, Andrea Visentin, et al.
American Journal of Hematology|September 29, 2011
Overexpression of HOXB7 and homeobox genes characterizes multiple myeloma patients lacking the major primary immunoglobulin heavy chain locus translocationsLuca Agnelli, Paola Storti, Katia Todoerti, et al.
European Journal of Cancer (Oxford, England : 1990)|December 28, 2016
Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patientsAndrea Visentin, Silvia Imbergamo, Carmela Gurrieri, et al.
International Journal of Laboratory Hematology|March 5, 2023
Higher accuracy of surgical over core needle biopsy for the diagnosis of lymphoproliferative disordersMarco Pizzi, Marta Sbaraglia, Luca Dal Santo, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 10, 2007
Hyperforin blocks neutrophil activation of matrix metalloproteinase-9, motility and recruitment, and restrains inflammation-triggered angiogenesis and lung fibrosisIsabella Dell'Aica, Raffaele Niero, Francesco Piazza, et al.
Oncotarget|January 5, 2018
Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: a report of three casesAndrea Visentin, Silvia Imbergamo, Federica Frezzato, et al.
Current Oncology (Toronto, Ont.)|January 20, 2023
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody DeficiencyAndrea Visentin, Maria Chiara Molinari, Stefano Pravato, et al.
Pageof 26